Franck Carbonnel
Inserm(FR)Université de Versailles Saint-Quentin-en-Yvelines(FR)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Centre de recherche en Epidémiologie et Santé des Populations(FR)Laboratoire d'études sur les monothéismes(FR)Bicêtre Hospital(FR)Bicêtre Hospital(FR)Icahn School of Medicine at Mount Sinai(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Cancer Immunotherapy and Biomarkers, Eosinophilic Esophagitis, Autoimmune and Inflammatory Disorders
Most-Cited Works
- → Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota(2015)3,336 cited
- → Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2017)2,321 cited
- → Immune-related adverse events with immune checkpoint blockade: a comprehensive review(2016)2,094 cited
- → Long-Term Evolution of Disease Behavior of Crohn's Disease(2002)1,346 cited
- → Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab(2017)1,280 cited
- → Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management(2017)1,154 cited